Corcept Therapeutics
CORT
#3439
Rank
A$6.03 B
Marketcap
A$57.25
Share price
-10.63%
Change (1 day)
-47.43%
Change (1 year)

Market capitalization of Corcept Therapeutics (CORT)

Market cap: A$6.03 Billion

As of February 2026 Corcept Therapeutics has a market cap of A$6.03 Billion. This makes Corcept Therapeutics the world's 3439th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Corcept Therapeutics from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026A$6.03 B-53.6%
2025A$13.00 B47.11%
2024A$8.83 B79.85%
2023A$4.91 B52.95%
2022A$3.21 B1.9%
2021A$3.15 B-20.22%
2020A$3.95 B99.65%
2019A$1.97 B-9.25%
2018A$2.18 B-17.37%
2017A$2.64 B136.08%
2016A$1.11 B49.2%
2015A$0.74 B101.65%
2014A$0.37 B3.44%
2013A$0.35 B161.62%
2012A$0.13 B-51.11%
2011A$0.28 B2.11%
2010A$0.27 B42.31%
2009A$0.19 B168.74%
2008A$71.94 M-48.53%
2007A$0.13 B248.13%
2006A$40.15 M-64.45%
2005A$0.11 B-38.24%
2004A$0.18 B

End of Day market cap according to different sources

On Jan 31st, 2026 the market cap of Corcept Therapeutics was reported to be:

A$6.02 Billion
by Nasdaq info icon info icon
A$6.03 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$786.22 B 12,932.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$409.67 B 6,690.63%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$215.87 B 3,478.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$1.335 T 22,030.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$395.51 B 6,456.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$160.92 B 2,567.55%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
A$2.54 B-57.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A$1.15 B-80.87%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$15.59 B 158.55%๐Ÿ‡บ๐Ÿ‡ธ USA